Literature DB >> 6774973

Isolation of an activation intermediate and determination of the amino acid sequence of the activation segment of human pepsinogen A.

T Kageyama, K Takahashi.   

Abstract

Upon activation of human pepsinogen A at pH 2.0 in the presence of pepstatin, an intermediate form was generated together with pepsin A. This activation intermediate could be separated from pepsinogen A and pepsin A by DE-32 cellulose chromatography at pH 5.5. It had a molecular weight intermediate between those of pepsinogen A and pepsin A, and contained about half the number of basic amino acid residues in pepsinogen A. It had phenylalanine as the amino(N)-terminal amino acid, and was deduced to be generated by release of N-terminal 25 residue segment from pepsinogen A. Amino acid sequence determination of the N-terminal portions of pepsinogen A and the intermediate from enabled us to elucidate the entire acid sequence of the 47-residue activation peptide segment as follow: [Formula: see text]. On the other hand, upon activation of pepsinogen A at pH 2.0 in the absence of pepstatin, cleavage of the activation segment occurred at several additional bonds. In addition, upon activation both in the presence and in the absence of pepsitatin, an additional activation intermediate, designated pepsin A', was formed in minor quantities. This form was identical with pepsin A, except that it had an additional Pro-Thr-Leu sequence preceding the N-terminal valine of pepsin A.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6774973     DOI: 10.1093/oxfordjournals.jbchem.a133005

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  6 in total

1.  Agmatine induces gastric protection against ischemic injury by reducing vascular permeability in rats.

Authors:  Abeer A Al Masri; Eman El Eter
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

2.  Discrepancies between gastric mucosal and urinary pepsinogen A patterns and in vitro synthesis and secretion of human pepsinogen.

Authors:  G Pals; B D Westerveld; J Defize; J C Pronk; H Brand; M Flipse; C Verwey; S G Meuwissen; A W Eriksson
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

Review 3.  Pepsinogen.

Authors:  B I Hirschowitz
Journal:  Postgrad Med J       Date:  1984-11       Impact factor: 2.401

4.  Inhibition of pepsin by analogues of pepsinogen-(1-12)-peptide with substitutions in the 4-7 sequence region.

Authors:  B M Dunn; M Lewitt; C Pham
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

Review 5.  Structure and function studies on enzymes with a catalytic carboxyl group(s): from ribonuclease T1 to carboxyl peptidases.

Authors:  Kenji Takahashi
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

6.  Pepsinogens I and II in gastric cancer: an immunohistochemical study using monoclonal antibodies.

Authors:  S C Huang; K Miki; J Sano; M Ichinose; N Kawamura; H Oka; K Hirano; C Furihata; Y Masugi; K Takahashi
Journal:  Jpn J Cancer Res       Date:  1988-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.